Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the FINDER(R) Flu A&B/SARS-CoV-2 Test, an ultra-rapid RT-PCR assay on the FINDER platform. This establishes FINDER as the first ...
Morning Overview on MSN
New BA.3.2 COVID variant spreads in US with immune-evasion mutations
A SARS-CoV-2 subvariant called BA.3.2, carrying a significant genomic deletion and mutations linked to immune evasion, has been detected among travelers arriving in the United States. The variant, ...
On March 29, 2020, Goa recorded its first SARS-CoV-2 fatality. Six years on, this anniversary demands a scientifically honest chronological reckoning — from that first death through the closure of the ...
Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.
December 2024 was declared a "high severity" flu season by the Centre for Disease Control (CDC), the worst in over half a decade. Hospitalization rates were up to 2.8 times higher than the median ...
BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen Testing to Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) MENLO PARK, Calif., ...
The World Health Organization (WHO) on 17 December 2025 announced the prequalification of two rapid antigen diagnostic tests (Ag-RDTs) for SARS-CoV-2, the virus responsible for COVID-19, marking a ...
December 26, 2025 - On 17 December 2025, the World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests (Ag-RDT) for SARS-CoV-2, the virus that causes ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Evaluation data on antigen ...
Researchers at Arizona State University have developed a breakthrough diagnostic tool that could transform how quickly and reliably we detect illnesses like COVID-19, Ebola, AIDS or Lyme disease. The ...
Low-cost nanoparticle blood test detects diseases like COVID-19, Ebola, AIDS, or Lyme in 15 minutes using just one drop of blood. (Nanowerk News) Researchers at Arizona State University have developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results